These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 90271

  • 1. Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.
    Atkinson AB, Davies DL, Leckie B, Morton JJ, Brown JJ, Fraser R, Lever AF, Robertson JI.
    Lancet; 1979 Sep 22; 2(8143):606-9. PubMed ID: 90271
    [Abstract] [Full Text] [Related]

  • 2. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI.
    Br Heart J; 1980 Sep 22; 44(3):290-6. PubMed ID: 7000102
    [Abstract] [Full Text] [Related]

  • 3. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
    Atkinson AB, Brown JJ, Davies DL, Leckie B, Lever AF, Morton JJ, Robertson JI.
    Hypertension; 1981 Sep 22; 3(1):53-8. PubMed ID: 7009427
    [Abstract] [Full Text] [Related]

  • 4. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
    Atkinson AB, Brown JJ, Fraser R, Leckie B, Lever AF, Morton JJ, Robertson JI.
    Clin Sci (Lond); 1979 Dec 22; 57 Suppl 5():139s-143s. PubMed ID: 396067
    [No Abstract] [Full Text] [Related]

  • 5. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome.
    Atkinson AB, Brown JJ, Cumming AM, Fraser R, Lever AF, Leckie BJ, Morton JJ, Robertson JI, Davies DL.
    Am J Cardiol; 1982 Apr 21; 49(6):1460-6. PubMed ID: 7041585
    [Abstract] [Full Text] [Related]

  • 6. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H, Uneda S, Tochikubo O, Ohonishi T, Harada J, Sesoko S, Goto E, Fujishima S, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1980 Jan 21; 22(1):13-22. PubMed ID: 6247528
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA, Steilner H, Hayduk K, Liebau G.
    Am J Cardiol; 1982 Apr 21; 49(6):1555-7. PubMed ID: 6803566
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition.
    Atkinson AB, Brown JJ, Fraser R, Lever AF, Morton JJ, Riegger AJ, Robertson JI.
    Clin Exp Hypertens (1978); 1980 Apr 21; 2(3-4):499-524. PubMed ID: 6253241
    [Abstract] [Full Text] [Related]

  • 13. Response of arterial blood pressure, plasma renin activity and plasma aldosterone concentration to long-term administration of captopril in patients with severe, treatment-resistant malignant hypertension.
    McCaa CS, Langford HG, Cushman WC, McCaa RE.
    Clin Sci (Lond); 1979 Dec 21; 57 Suppl 5():371s-373s. PubMed ID: 396084
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of captopril on the renin-angiotensin system in hypertensive children.
    Friedman AL, Chesney RW.
    J Pediatr; 1983 Nov 21; 103(5):806-10. PubMed ID: 6355422
    [Abstract] [Full Text] [Related]

  • 16. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB, Cumming AM, Brown JJ, Fraser R, Leckie B, Lever AF, Morton JJ, Robertson JI.
    Br J Clin Pharmacol; 1982 Jun 21; 13(6):855-8. PubMed ID: 7046776
    [Abstract] [Full Text] [Related]

  • 17. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.
    Staessen J, Lijnen P, Fagard R, Verschueren LJ, Amery A.
    J Endocrinol; 1981 Dec 21; 91(3):457-65. PubMed ID: 7035596
    [Abstract] [Full Text] [Related]

  • 18. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA, Baker KM, Ayers CR, Weaver BA, Lehman MR.
    J Cardiovasc Pharmacol; 1985 Dec 21; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [Abstract] [Full Text] [Related]

  • 19. Captopril in the treatment of clinical hypertension and cardiac failure.
    Atkinson AB, Robertson JI.
    Lancet; 1979 Oct 20; 2(8147):836-9. PubMed ID: 90928
    [No Abstract] [Full Text] [Related]

  • 20. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
    Eguchi T, Saito I, Nakamura R, Yasui T, Saruta T.
    Acta Endocrinol (Copenh); 1980 Jun 20; 94(2):213-20. PubMed ID: 6251687
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.